What is a clinically significant erythrocyte (red blood cell) count in urine microscopic examinations (mcs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A clinically significant erythrocyte count in urine microscopy and culture (MCS) is defined as more than 3 red blood cells per high-power field (>3 RBCs/HPF) according to the most recent guidelines. This definition is based on the American Urological Association (AUA) and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) guideline published in 2020 1. The guideline emphasizes that clinicians should define microhematuria as >3 RBCs/HPF on microscopic evaluation of a single, properly collected urine specimen.

The clinical significance of erythrocyte count in urine MCS depends on various factors, including the patient's symptoms, medical history, and other laboratory findings. Isolated hematuria without symptoms may require monitoring, while hematuria with symptoms like pain, fever, or decreased urine output needs prompt evaluation. The context matters significantly, as temporary and benign causes such as menstruation in women, strenuous exercise, or certain medications can cause hematuria.

Key points to consider in evaluating the clinical significance of erythrocyte count in urine MCS include:

  • The presence of red blood cells in urine can indicate various conditions, including urinary tract infections, kidney stones, glomerular disease, trauma, or malignancy.
  • Quantification of RBCs is important, as higher counts generally suggest more significant pathology requiring urgent assessment.
  • The AUA/SUFU guideline recommends a risk classification system for patients with microhematuria, stratified as low-, intermediate-, or high-risk for genitourinary malignancy, based on factors such as age, sex, smoking, and degree and persistence of microhematuria 1.

In clinical practice, defining microhematuria as >3 RBCs/HPF provides a clear threshold for further evaluation and management, taking into account the patient's individual risk factors and clinical presentation.

From the Research

Clinically Significant Erythrocyte Count

  • A clinically significant erythrocyte count on urine microscopy is generally considered to be three to five red blood cells per high-power field 2.
  • The presence of erythrocytes in urine can be an indicator of various conditions, including urinary tract infections, kidney disease, and urinary tract neoplasms.
  • The diagnostic value of urine tests, including erythrocyte count, can vary depending on the method used, with urine sediment microscopy being more sensitive than automated urinalysis for detecting red and white blood cells 3.

Diagnostic Considerations

  • The presence of proteinuria, red cell casts, and elevated serum creatinine levels in addition to hematuria may indicate a more serious underlying condition and warrants prompt referral to a nephrology subspecialist 2.
  • Patients with asymptomatic microscopic hematuria or persistent hematuria after treatment of a urinary tract infection require further evaluation, including cytology and imaging studies such as intravenous urography, computed tomography, or ultrasonography 2.
  • Abnormal urine cytology results should be followed up with cystoscopy to complete the investigation 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Assessment of microscopic hematuria in adults.

American family physician, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.